Sleep disorders are common but underrecognized manifestations of corticobasal syndrome (CBS), affecting a significant proportion of patients throughout the disease course. While classically considered a movement disorder characterized by asymmetric rigidity, apraxia, and cortical sensory loss, CBS frequently involves sleep architecture disruption that impacts quality of life, caregiver burden, and potentially serves as a biomarker of underlying pathology["1"]. Understanding sleep disturbances in CBS is important for comprehensive patient care and may provide insights into disease progression and neuroanatomical involvement.
Sleep disorders are common but underrecognized manifestations of corticobasal syndrome (CBS), affecting a significant proportion of patients throughout the disease course. While classically considered a movement disorder characterized by asymmetric rigidity, apraxia, and cortical sensory loss, CBS frequently involves sleep architecture disruption that impacts quality of life, caregiver burden, and potentially serves as a biomarker of underlying pathology["1"]. Understanding sleep disturbances in CBS is important for comprehensive patient care and may provide insights into disease progression and neuroanatomical involvement.
The prevalence of sleep disorders in CBS varies by study and sleep disorder type, but estimates suggest 40-70% of patients experience significant sleep disturbances["2"]. This is higher than in some other parkinsonian disorders but lower than in multiple system atrophy (MSA), where sleep dysfunction is a defining feature.
REM sleep behavior disorder (RBD) is characterized by loss of normal muscle atonia during REM sleep, leading to dream-enacting behaviors ranging from simple limb movements to complex behaviors including shouting, punching, kicking, or falling out of bed[1]. Patients are often unaware of these behaviors, which are typically reported by bed partners.
In CBS, RBD appears less frequently than in synucleinopathies (PD, MSA, DLB) but is more common than in primary tauopathies like progressive supranuclear palsy (PSP)[2]. Several studies have documented RBD in approximately 20-30% of CBS patients, though this varies based on underlying pathology[3].
The presence of RBD in CBS reflects involvement of brainstem structures that regulate REM sleep atonia, particularly the sublaterodorsal nucleus and coeruleus nucleus in the pons. While CBS is classically considered a cortical-subcortical disorder, emerging evidence suggests that brainstem structures may be involved in the disease process, particularly in cases with underlying Lewy body pathology (alpha-synuclein)[4].
RBD in CBS has several important implications:
Management of RBD in CBS includes:
Insomnia and sleep fragmentation are among the most common sleep complaints in CBS, affecting up to 60-70% of patients[2]. Difficulty falling asleep, frequent nighttime awakenings, and early morning awakening are all reported.
Several factors contribute to insomnia in CBS:
Management of insomnia in CBS should be multidimensional:
Obstructive sleep apnea (OSA) is increasingly recognized in CBS patients, with some studies suggesting prevalence rates of 30-50%[5]. Contributing factors include:
Central sleep apnea, including Cheyne-Stokes respiration, occurs less frequently but has been reported in CBS, particularly in advanced disease stages. This may reflect brainstem involvement or cardiac dysfunction.
Symptoms of sleep-disordered breathing in CBS include:
Treatment options for sleep-disordered breathing in CBS include:
Restless legs syndrome (RLS) has been reported in CBS patients, though less commonly than in PD. The characteristic uncomfortable sensations in the legs at rest, worse in the evening, and improved by movement can significantly impact sleep onset.
Periodic limb movements during sleep (PLMS) are common in CBS, occurring in up to 40% of patients. These repetitive limb movements can fragment sleep and contribute to excessive daytime sleepiness.
Management includes:
Excessive daytime sleepiness (EDS) in CBS is multifactorial:
Emerging evidence suggests that sleep disturbances in CBS may correlate with disease progression and could serve as biomarkers[4]. Patients with more severe sleep dysfunction tend to have:
Circadian rhythm disturbances have been documented in CBS, including:
Sleep disorders in CBS frequently interact with neuropsychiatric symptoms:
Sleep disturbances in CBS significantly impact caregivers:
Sleep disorders are common and impactful in CBS, affecting 40-70% of patients. RBD, insomnia, sleep-disordered breathing, and daytime sleepiness are the most prevalent issues. Systematic sleep assessment should be part of CBS management, and comprehensive treatment approaches addressing both motor and sleep symptoms optimize patient and caregiver quality of life. Sleep disturbances may also serve as biomarkers of underlying pathology and disease progression.
The following diagram shows the key molecular relationships involving sleep-disorders-in-corticobasal-syndrome discovered through SciDEX knowledge graph analysis:
Gene: CBS
| Variant | Clinical Significance | Conditions |
|---|---|---|
| NM_000071.3(CBS):c.847G>T (p.Glu283Ter) | Likely pathogenic | Classic homocystinuria |
| NM_000071.3(CBS):c.846dup (p.Glu283fs) | Likely pathogenic | Classic homocystinuria |
| NM_000071.3(CBS):c.833delinsCTGGGGTGGATCATCCAGGTGGGGCTTTTGCT | Likely pathogenic | Classic homocystinuria |
| NM_000071.3(CBS):c.700_702del (p.Asp234del) | Likely pathogenic | Classic homocystinuria |
| NM_000071.3(CBS):c.615_625delinsAACTGTGGG (p.Val206fs) | Likely pathogenic | Classic homocystinuria |
| NM_000071.3(CBS):c.518_520del (p.Met173del) | Likely pathogenic | Classic homocystinuria |
| NM_000071.3(CBS):c.316+2T>C | Likely pathogenic | Classic homocystinuria |
| NM_000071.3(CBS):c.210-2A>G | Pathogenic | Classic homocystinuria |